BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to ...

Iconiq Growth, the venture arm of investment firm Iconiq Capital, has hired cloud-based analytics firm Datadog's President ...

It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that together create a wide economic moat. J&J holds a leadership role in diverse healthcare ...

The firm's recent hires have focused on former executives from major companies, so-called operators—rather than career investors, including Alex Gorsky, former CEO of Johnson & Johnson.

The announcement is likely to be one of the last major strategic moves undertaken by J&J chief executive Alex Gorsky, who will hand over the reins to CEO-elect Joaquin Duato on 1 January.

Explaining its decision to separate its consumer health unit, former CEO and chairman, Alex Gorsky, stated at the time of the announcement: “For the new Johnson & Johnson, this planned ...